Leronlimab - Merck Could Merck be slow playing Le
Post# of 157708

Could Merck be slow playing Leronlimab since they know how we do against Keytruda and with Keytruda? Ohm once said that we are probably better than Keytruda alone. Correct me Ohm if I misquoted. No harm intended. This way Merck can continue on making big bucks with Keytruda and then step right into Leronlimab. Just a thought, as there is no proof of Merck as our partner / Acquirer although that is where I am pointing.

